Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease.
暂无分享,去创建一个
L. Moran | M. Graeber | S. Gentleman | R. Pearce | M E Kalaitzakis | L M Christian | L B Moran | M B Graeber | R K B Pearce | S M Gentleman | R. Pearce | M. Kalaitzakis | L. Christian
[1] I. Alafuzoff,et al. α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.
[2] M. Graeber,et al. Comparative study of commercially available anti‐α‐synuclein antibodies , 2006, Neuropathology and applied neurobiology.
[3] 이필휴. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies , 2007 .
[4] W. Poewe. Psychosis in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[5] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[6] J. Cummings,et al. Frequency of dementia in Parkinson disease. , 1996, Archives of neurology.
[7] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[8] A. Parent. Extrinsic connections of the basal ganglia , 1990, Trends in Neurosciences.
[9] Joseph E Parisi,et al. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.
[10] C. Marsden,et al. HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE? , 1984, The Lancet.
[11] M. Botvinick,et al. Parsing executive processes: strategic vs. evaluative functions of the anterior cingulate cortex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] Mrc Psych,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .
[13] D. Dickson,et al. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease , 2000, Acta Neuropathologica.
[14] G. Halliday,et al. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.
[15] M. Serby,et al. Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. , 1978, The American journal of psychiatry.
[16] J. Cummings,et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. , 1999, Archives of neurology.
[17] R E Harlan,et al. The accumbens: beyond the core-shell dichotomy. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[18] J. Troncoso,et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. , 2005, Neurobiology of aging.
[19] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[20] A. David,et al. Visual hallucinations in Parkinson's disease: a review and phenomenological survey , 2001, Journal of neurology, neurosurgery, and psychiatry.
[21] P. Lantos,et al. Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease , 1996, Neuroscience Letters.
[22] D. Dickson,et al. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease , 1998, Acta Neuropathologica.
[23] L. Hazrati,et al. Functional anatomy of the basal ganglia , 1995 .
[24] H. Klawans,et al. Levodopa-induced psychosis: a kindling phenomenon. , 1978, The American journal of psychiatry.
[25] David R Williams,et al. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study , 2005, The Lancet Neurology.
[26] Joon-Kee Yoon,et al. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies , 2007, European journal of neurology.
[27] M. Graeber,et al. Striatal &bgr;-Amyloid Deposition in Parkinson Disease With Dementia , 2008, Journal of neuropathology and experimental neurology.
[28] S. Papapetropoulos,et al. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease? , 2005, Acta neurologica Scandinavica.
[29] Deborah C Mash,et al. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. , 2006, Parkinsonism & related disorders.
[30] C. Shepherd,et al. Relationship between neuronal loss and ‘inflammatory plaques’ in early onset Alzheimer's disease , 2007, Neuropathology and applied neurobiology.
[31] M. MacDonald,et al. An Improved Approach to Prepare Human Brains for Research , 1995, Journal of neuropathology and experimental neurology.
[32] M. Barcikowska,et al. Dementia in Parkinson's disease. , 1994, Dementia.
[33] D. Aarsland,et al. Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study , 2005, Annals of neurology.
[34] G. Wooten,et al. Prospective study of hallucinations and delusions in Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[35] C. Goetz,et al. Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.
[36] K. Jellinger,et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. , 1998, Archives of neurology.
[37] G. Halliday,et al. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.
[38] Lipton Ra,et al. Letter: Factor VIII. , 1973, Lancet.
[39] K. Jellinger. Striatal beta-amyloid deposition in Parkinson disease with dementia. , 2008, Journal of neuropathology and experimental neurology.
[40] J. Cummings,et al. Range of neuropsychiatric disturbances in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[41] G. Stebbins,et al. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model , 2005, Movement disorders : official journal of the Movement Disorder Society.
[42] G. Fénelon,et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.
[43] R. Grünewald,et al. Hallucinosis in idiopathic Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.
[44] Glenda M. Halliday,et al. Cortical Lewy body pathology in the diagnosis of dementia , 2001, Acta Neuropathologica.
[45] P. Hof,et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease , 2003, Acta Neuropathologica.
[46] B. Vogt,et al. Contributions of anterior cingulate cortex to behaviour. , 1995, Brain : a journal of neurology.
[47] J. Rinne,et al. Neuritic degeneration in the hippocampus and amygdala in Parkinson’s disease in relation to Alzheimer pathology , 1999, Acta Neuropathologica.
[48] G. Glosser,et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.
[49] Y. Agid,et al. Confusion, dementia and anticholinergics in Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[50] J. Sanchez-Ramos,et al. Visual hallucinations associated with Parkinson disease. , 1996, Archives of neurology.
[51] J. Troncoso,et al. Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases , 2005, Neurobiology of Aging.
[52] A. Lees,et al. Parkinson's Disease Society Brain Bank, London: overview and research. , 1993, Journal of neural transmission. Supplementum.
[53] I. Ferrer,et al. Assessment of &agr;-Synuclein Pathology: A Study of the BrainNet Europe Consortium , 2008, Journal of neuropathology and experimental neurology.
[54] S. J. Newman,et al. A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. , 1997, Neuroreport.
[55] R. Harper,et al. Coloured Lilliputian Hallucinations with Amantadine , 1973, The Medical journal of Australia.
[56] I. Ferrer,et al. Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium , 2006, Journal of neuropathology and experimental neurology.
[57] A. Lees,et al. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease , 1997, Neurology.
[58] J. Feigenson,et al. Piribedil: Its synergistic effect in multidrug regimens for parkinsonism , 1976, Neurology.
[59] J. Cummings. Behavioral Complications of Drug Treatment of Parkinson's Disease , 1991, Journal of the American Geriatrics Society.
[60] A. Dale,et al. Dorsal anterior cingulate cortex: A role in reward-based decision making , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Trojanowski,et al. Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.
[62] T. Paus. Primate anterior cingulate cortex: Where motor control, drive and cognition interface , 2001, Nature Reviews Neuroscience.
[63] A. Lees,et al. Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients , 2008, Acta Neuropathologica.
[64] H. Braak,et al. Pattern of brain destruction in Parkinson's and Alzheimer's diseases , 2005, Journal of Neural Transmission.
[65] D. Mash,et al. Dementia in Parkinson's disease: a post‐mortem study in a population of brain donors , 2005, International journal of geriatric psychiatry.
[66] Dc Washington. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .